본문 바로가기
bar_progress

Text Size

Close

Cellivery, Toxicity Test of Intrinsic Immunity Control Therapeutic is Safe!

Those who applied for hit the upper limit price in just one day! Achieved 31% profit!

Congratulations to everyone who applied for the free trial. ^^


※ For those who missed the “COVID-19 treatment,” it’s okay. We are going out big once again.

※ Finally starting. PARKUS(065690) follow-up stock hits the upper limit price on Tuesday. ※


▶▶ Starting huge with the ‘upper limit price’ on September 1st, COVID-19 immune treatment toxicity test! ‘ㅇㅇㅇㅇㅇ’ related stock! ▶ Apply for free trial ◀


Cellivery announced that it has received the interim report on the safety evaluation test results of the innate immune control antiviral drug under development as a COVID-19 treatment!!

The key point is that high doses above the effective concentration administered to humans were repeatedly given to small animals, and histopathological analysis found no evidence of any toxicity!!



▶▶ Heading straight ‘up’ on Tuesday. Moving fast, COVID-19 immune treatment toxicity test! Beneficiary stocks! Don’t miss out [Apply now for ‘COVID-19 immune treatment toxicity test’ related stocks]


"It was so difficult to trade stocks alone." I asked acquaintances for advice here and there, but I never made a proper profit even once. So I thought to get advice from an expert and first applied for a 3-day free trial! Wow! Experts are really different. I am still receiving the service now, and looking back, I think it was a great decision. Thank you.

(VIP office worker Kim Minji, 46 years old member)


Now think this is the last chance. If you miss this opportunity, you have to quit.

Exactly on “September 1st” it will explode! Don’t miss out and regret it, buy at least with 100,000 KRW!



▶▶ “September 1st upper limit price” offered only until today and then closed. [Receive stocks related to ‘COVID-19 immune treatment toxicity test’!] ▶ Receive stocks ◀


[AI recent upper limit price hits]

*20.08.28 PARKUS(065690) hit upper limit!

*20.08.27 Bodytech Med (206640) hit upper limit!

*20.08.26 Telcon RF Pharma (200230) hit upper limit!

*20.08.25 Woori Bio (082850) hit upper limit!

*20.08.24 Jinwon Life Science (011000) hit upper limit!

*20.08.21 Exa Inc. (054940) hit upper limit!

*20.08.20 Wooridul Pharma (004720) 3 consecutive upper limit hits!

*20.08.19 Wooridul Pharma (004720) 2 consecutive upper limit hits!

*20.08.18 Wooridul Pharma (004720) hit upper limit!

*20.08.14 KNN (058400) hit upper limit!

*20.08.13 HL Biotech (028300) hit upper limit!

*20.08.12 Ilsin Bio (068330) hit upper limit!

*20.08.11 Korea BioGen (318000) hit upper limit!

*20.08.10 CIS (222080) hit upper limit!

*20.08.07 Seoyeon Top Metal (019770) hit upper limit!

*20.08.06 Hyosung O&B (097870) hit upper limit!

*20.08.05 DA Technology (196490) hit upper limit!

*20.08.04 Kainos Med (284620) hit upper limit!

*20.08.03 Access Bio (950130) hit upper limit!

*20.07.31 BioSmart (038460) hit upper limit!

*20.07.30 Simtek (222800) hit upper limit!

*20.07.29 Bitsro Tech (042370) hit upper limit!


▶▶ Only 10 people! “Tuesday upper limit price”! ▶ Receive now ◀


※ First-come, first-served 10 people closed! Both early and late rounds are finished. The hero of the last injury time winning goal ※


[Today’s stocks of interest]

#Hyundai Pharm #Myungmoon Pharm #Vynex #Shinshin Pharm #Celltrion Healthcare


※ This content is unrelated to the editorial direction of Asia Economy, and all responsibility lies with the information provider.


© The Asia Business Daily(www.asiae.co.kr). All rights reserved.


Join us on social!

Top